Alirocumab: A New Cholesterol Lowering Drug Received FDA Advisory Panel Approval
US FDA advisory panel has suggested the approval of a new, injectable cholesterol-lowering drug known as alirocumab, though many panel
Read moreUS FDA advisory panel has suggested the approval of a new, injectable cholesterol-lowering drug known as alirocumab, though many panel
Read more